ProQR Therapeutics Stock (NASDAQ:PRQR), Quotes and News Summary

Q: What sector and industry does ProQR Therapeutics (PRQR) operate in?

ProQR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

ProQR Therapeutics Stock (NASDAQ: PRQR) stock price, news, charts, stock research, profile.

Open	$1.900
Close	-
Volume / Avg.	49.354K / 247.425K
Day Range	1.865 - 2.000
52 Wk Range	1.110 - 3.290
Market Cap	$155.395M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	0.45%
Days to Cover	1.83

Recent News

Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the consensus of $1.532 billion. Adjusted EPS of 25 cents topped the street view of 23 cents.

Avi Kapoor

Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announced a partnership with GCT Semiconductor to develop an RF module. Airspan Networks Holdings shares surged 381% to $0.3699 on Wednesday.

Avi Kapoor

US Stocks Lower; Dow Falls Over 50 Points

U.S. stocks traded lower this morning, with the Dow Jones index falling over 50 points on Monday. Following the market opening Monday, the Dow traded down 0.18% to 35,328.05 while the NASDAQ fell 0.13% to 14,231.78. The S&P 500 also fell, dropping, 0.25% to 4,548.14.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About

Sector

Healthcare

Industry

N/A

ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics fo...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy ProQR Therapeutics (PRQR) stock?

You can purchase shares of ProQR Therapeutics (NASDAQ: PRQR) through any online brokerage.

View our list of the best stock brokerages.

Who are ProQR Therapeutics's (PRQR) competitors?

There are no as such competitors for ProQR Therapeutics.

What is the target price for ProQR Therapeutics (PRQR) stock?

The latest price target for ProQR Therapeutics (NASDAQ: PRQR) was reported by Citigroup on Thursday, April 18, 2024. The analyst firm set a price target for 2.00 expecting PRQR to rise to within 12 months (a possible 4.71% upside). 12 analyst firms have reported ratings in the last year.

Current Stock Price for ProQR Therapeutics (PRQR)?

The stock price for ProQR Therapeutics (NASDAQ: PRQR) is $1.9101 last updated Today at April 19, 2024 at 9:25 AM EDT.

Does ProQR Therapeutics (PRQR) pay a dividend?

There are no upcoming dividends for ProQR Therapeutics.

When is ProQR Therapeutics (NASDAQ:PRQR) reporting earnings?

ProQR Therapeutics’s Q1 earnings are confirmed for Tuesday, May 14, 2024.

Is ProQR Therapeutics (PRQR) going to split?

There is no upcoming split for ProQR Therapeutics.

What sector and industry does ProQR Therapeutics (PRQR) operate in?

ProQR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.